Recent News

• 12.10.2025 - Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
• 12.08.2025 - Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
• 12.08.2025 - Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
• 12.07.2025 - Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

Recent Filings

• 12.09.2025 - 144 Report of proposed sale of securities
• 12.08.2025 - 144 Report of proposed sale of securities
• 12.08.2025 - 8-K Current report
• 12.08.2025 - 144 Report of proposed sale of securities
• 12.08.2025 - 144 Report of proposed sale of securities
• 12.08.2025 - 144 Report of proposed sale of securities
• 12.08.2025 - 144 Report of proposed sale of securities
• 12.08.2025 - 144 Report of proposed sale of securities
• 12.08.2025 - EX-99.1 EX-99.1
• 12.08.2025 - 424B5 Prospectus [Rule 424(b)(5)]